Clara García-Astrain, postdoctoral researcher at the BioNanoPlasmonics group, has been interviewed by REGENHU, a Swiss Med Tech company that creates and develops bioprinting technologies, in the frame of “Women in Bioprinting” campaign.
Clara is using bioprinting to develop 3D cell models to help shed more light on cancer and tissue tumor growth.
Read the interview here